EASTPHARMA LTD.
London, 07 August 2012 - EastPharma (EAST LI), a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets, informs that it will be announcing its H1 2012 reviewed financial statements and a review of its main subsidiary DEVA Holding's financial statements for the related period on 23 August 2012.
A conference call to review the H1 2012 financial performance will be hosted by the management of EastPharma at 4:00pm London time on 29 August 2012 (11:00am New York / 5:00pm Zurich time / 6:00pm Istanbul time). The dial-in details are provided below.
Conference call:
Dial-in Number (UK): + 44 (0)20 7162 0077
Dial-in Number (US): + 1 877 491 0064
Dial-in Number (Switzerland): + 41 (0)434 5692 61
Dial-in Number (Germany): + 49 (0)695 8999 0507
Conference ID: 921086
For further information, please contact:
Investor Relations:
email: ir@eastpharmaltd.com